In the SARS-CoV-2 Pandora Pandemic: Can the Stance of Premorbid Intestinal Innate Immune System as Measured by Fecal Adnab-9 Binding of p87:Blood Ferritin, Yielding the FERAD Ratio...

por Tobi, Martin, Bluth, Martin H., Rossi, Noreen F., Demian, Ereny, Talwar, Harvinder, Tobi, Yosef Y., Sochacki, Paula, Levi, Edi, Lawson, Michael, McVicker, Benita
Publicado 2023

Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

por Poels, Kamrine E., Schoenfeld, Adam J., Makhnin, Alex, Tobi, Yosef, Wang, Yuli, Frisco-Cabanos, Heidie, Chakrabarti, Shaon, Shi, Manli, Napoli, Chelsi, McDonald, Thomas O., Tan, Weiwei, Hata, Aaron, Weinrich, Scott L., Yu, Helena A., Michor, Franziska
Publicado 2021

Author Correction: Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

por Poels, Kamrine E., Schoenfeld, Adam J., Makhnin, Alex, Tobi, Yosef, Wang, Yuli, Frisco-Cabanos, Heidie, Chakrabarti, Shaon, Shi, Manli, Napoli, Chelsi, McDonald, Thomas O., Tan, Weiwei, Hata, Aaron, Weinrich, Scott L., Yu, Helena A., Michor, Franziska
Publicado 2022

Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations

por Arbour, Kathryn C., Manchado, Eusebio, Bott, Matthew J., Ahn, Linda, Tobi, Yosef, Ni, Andy Ai, Yu, Helena A., Shannon, Alyssa, Ladanyi, Marc, Perron, Victoria, Ginsberg, Michelle S., Johnson, Amanda, Holodny, Andrei, Kris, Mark G., Rudin, Charles M., Lito, Piro, Rosen, Neal, Lowe, Scott, Riely, Gregory J.
Publicado 2021